Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)
Hong Kong
· Delayed Price · Currency is HKD 74.90
-4.10 (-5.19%)
At close: Apr 29, 2026
HKG:2659 Market Cap
HKG:2659 has a market cap or net worth of 25.75 billion as of April 29, 2026.
Market Cap
25.75B
Enterprise Value
24.72B
Revenue
54.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
74.90
Market Cap Chart
Since December 10, 2025, HKG:2659's market cap has increased from 20.54B to 25.75B, an increase of 25.40%. That is a compound annual growth rate of 80.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 24.42B | -3.42% |
| Dec 31, 2025 | 25.28B | 23.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Duality Biotherapeutics | 26.43B |
| TransThera Sciences (Nanjing) | 23.68B |
| Keymed Biosciences | 22.39B |
| InnoCare Pharma | 29.74B |
| Genscript Biotech | 30.30B |
| Ascletis Pharma | 20.32B |
| Zai Lab | 20.04B |
| Ascentage Pharma Group International | 17.22B |